
FDA 510(K), MDSAP
EXO Advantage delivers the equipment and protocols available to the nation’s blood banks but customized to meet the needs of the clinic.
Research has shown that an absolute count of over 10 billion platelets and over 1.5 billion platelets per ml is the threshold for PRP dosage to optimally treat knee OA. The Exo Advantage system consistently delivers over 10 billion platelets.
Are you pre-conditioning your samples using photobiomodulation?
Does your clinical regimen include supplementing your PRP with concentrated proteins and exosomes from plasma?
Are you processing PRP, Exosomes, bone marrow, and adipose using a common platform to improve workflow?
Access superior biologics at a guaranteed lower cost and a threshold over 10 billion platelets for your typical OA patient.

At Exo Advantage, we believe clinicians deserve access to safe, novel, and affordable cutting-edge solutions for treating patients.
Providing the regenerative medicine community with cutting-edge protocols and devices to consistently meet or exceed dose thresholds at the lowest cost.
-
Unique Capabilities
-
Industry-Leading Protocols Set By The Red Cross & Blood Banks
-
Improved Quality of Biologics - Higher Platelet Count per Sample
-
Increased Efficiency and Ease of Use with Common Platform
-
Lower Costs and Transparent Pricing
You Deserve a MUCH Better Product at a MUCH Better Price
BETTER FOR PROVIDERS
Adopt cutting-edge protocols for higher dose, mitochondrial repair, and more concentrated exosome, protein and growth factors
BETTER FOR PATIENTS
Superior Biologics Lead to Better Patient Outcomes
We can dramatically lower your costs and improve the quality of the biologics you use!

Dr. Paul Tortland, DO, FAOASM